Evidence map›Paper›PMID 26909048›Full record

ArticleFrontiers in psychiatry2016

Altered SPECT (123)I-iomazenil Binding in the Cingulate Cortex of Children with Anorexia Nervosa.

Shinichiro Nagamitsu, Rieko Sakurai, Michiko Matsuoka, Hiromi Chiba, Shuichi Ozono, Hitoshi Tanigawa, Yushiro Yamashita, Hayato Kaida, Masatoshi Ishibashi, Tatsuki Kakuma and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Shinichiro NagamitsuDepartment of Pediatrics and Child Health, Kurume University School of Medicine , Fukuoka , Japan.
Rieko SakuraiGraduate School of Medicine, Kurume University , Fukuoka , Japan.
Michiko MatsuokaDepartment of Psychiatry, Kurume University School of Medicine , Fukuoka , Japan.
Hiromi ChibaDepartment of Psychiatry, Kurume University School of Medicine , Fukuoka , Japan.
Shuichi OzonoDepartment of Pediatrics and Child Health, Kurume University School of Medicine , Fukuoka , Japan.
Hitoshi TanigawaCenter of Diaginostic Imaging, Kurume University Hospital , Fukuoka , Japan.
Yushiro YamashitaDepartment of Pediatrics and Child Health, Kurume University School of Medicine , Fukuoka , Japan.
Hayato KaidaDepartment of Radiology, Kinki University Faculty of Medicine , Osakasayama , Japan.
Masatoshi IshibashiDepartment of Radiology, Kurume University School of Medicine , Fukuoka , Japan.
Tatsuki KakumaBiostatistics Center, Kurume University School of Medicine , Fukuoka , Japan.
Paul E CroarkinDepartment of Psychiatry and Psychology, Mayo Clinic , Rochester, MN , USA.
Toyojiro MatsuishiDepartment of Pediatrics and Child Health, Kurume University School of Medicine , Fukuoka , Japan.
Kurume University · JPKindai University · JPKurume University Hospital · JPWinnMed · US

Funding

Glutamate Probes in Adolescent DepressionK23MH100266 · NIMH · MAYO CLINIC ROCHESTER · PI CROARKIN, PAUL E · 2014 to 2017
$685k
NIMH NIH HHS K23 MH100266
6 · The paper itself

Abstract

Several lines of evidence suggest that anxiety plays a key role in the development and maintenance of anorexia nervosa (AN) in children. The purpose of this study was to examine cortical GABA(A)-benzodiazepine receptor binding before and after treatment in children beginning intensive AN treatment. Brain single-photon emission computed tomography (SPECT) measurements using (123)I-iomazenil, which binds to GABA(A)-benzodiazepine receptors, was performed in 26 participants with AN who were enrolled in a multimodal treatment program. Sixteen of the 26 participants underwent a repeat SPECT scan immediately before discharge at conclusion of the intensive treatment program. Eating behavior and mood disturbances were assessed using Eating Attitudes Test with 26 items (EAT-26) and the short form of the Profile of Mood States (POMS). Clinical outcome scores were evaluated after a 1-year period. We examined association between relative iomazenil-binding activity in cortical regions of interest and psychometric profiles and determined which psychometric profiles show interaction effects with brain regions. Further, we determined if binding activity could predict clinical outcome and treatment changes. Higher EAT-26 scores were significantly associated with lower iomazenil-binding activity in the anterior and posterior cingulate cortex. Higher POMS subscale scores were significantly associated with lower iomazenil-binding activity in the left frontal, parietal cortex, and posterior cingulate cortex (PCC). "Depression-Dejection" and "Confusion" POMS subscale scores, and total POMS score showed interaction effects with brain regions in iomazenil-binding activity. Decreased binding in the anterior cingulate cortex and left parietal cortex was associated with poor clinical outcomes. Relative binding increases throughout the PCC and occipital gyrus were observed after weight gain in children with AN. These findings suggest that cortical GABAergic receptor binding is altered in children with AN. This may be a state-related change, which could be used to monitor and guide the treatment of eating disorders.

Indexed as

anorexia nervosachildrencingulate cortexGABAiomazenil SPECT

Identifiers

PMID26909048
PMCPMC4754452
OpenAlexW2303458100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.